about
Mast cells in inflammatory arthritisInflammatory gout: observations over a half-century.Examination of complement C3 metabolism in rheumatoid arthritis using 2-dimensional immunoelectrophoresis.Gold and penicillamine: a proposed mode of action in rheumatoid arthritis, based on synovial fluid analysis.Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase.Complement-fixing activity of rheumatoid synovial fluid.High levels of serum complement factors in juvenille rheumatoid arthritisComplement metabolism in the seronegative arthritides.Complement and immunoglobulins in synovial fluid from synovectomized patients with rheumatoid arthritis.Relation of titred peripheral pattern ANA to anti-DNA and disease activity in systemic lupus erythematosus.Complement system in synovial fluids from patients with rheumatoid arthritis.Exchange of IgM and albumin between plasma and synovial fluid in rheumatoid arthritis.Complement-derived leukotactic factors in inflammatory synovial fluids of humans.In vitro synthesis of immunoglobulin by rheumatoid synovial membrane.A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis.Immunoglobulins and complement components in synovial fluid of patients with acute rheumatic fever.Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factorC3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities.Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1Immune complexes in human diseases: a reviewRegulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritisAspects of science in Scandinavian rheumatology--the making of a specialty.Mechanisms of inflammation in gout.Metabolism of autologous and homologous IgG in rheumatoid arthritisA broad screen for targets of immune complexes decorating arthritic joints highlights deposition of nucleosomes in rheumatoid arthritis.Therapeutic effects of sesame oil on monosodium urate crystal-induced acute inflammatory response in rats.Complement in the immunopathogenesis of rheumatic disease.Neutrophils, IL-1β, and gout: is there a link?New knowledge of the pathogenesis of gout.Crystals and inflammation.Soluble immune complexes in human disease.Comparative morphology, respiration, and phagocytic function of leukocytes from blood and joint fluid in rheumatoid arthritis.Breakdown products of C 3 in human synovial fluidsImmune complex-mediated rheumatic diseases: the evidence and the enigmas.Survey of synovial fluid cryoprecipitates.Activation of the alternative pathway of complement by monosodium urate monohydrate crystals and other inflammatory particles.Immunoglobulins and complement in pleural effusions associated with bronchogenic carcinoma.Corynebacterium acnes in rheumatoid arthritis. II. Identification of antigen in synovial fluid leucocytes.
P2860
Q24798636-68314555-49E1-4821-AA8C-2D218AE0BB9FQ30525648-C598E480-2DCE-499E-AEE7-130B7B25873AQ33551324-7187DE0F-453D-4C84-920B-6D360264BB04Q33551646-82767B6B-0D44-489D-A4E9-39A592454E3FQ33557184-026DFD8D-2703-4E45-875D-D8AA000EEBFBQ33563013-DAE4A51B-6EFE-415E-8423-030BF1AB7DE9Q33568264-C812C2AB-97D6-477C-9F6E-8BEB0041D372Q33568957-FE63C152-7DD3-4C5D-9367-79CAC69E2CB6Q33569147-6E15D370-D3FC-4ADC-990B-B0FBF98C7EDCQ33569703-980D4EA2-9A56-4F41-AE45-97B61C20A61EQ33569878-27FB68DC-E4C4-46A2-A38D-5E7A5EA39CC0Q33580015-0FC9AC2F-6822-481B-AB95-E2680175AE02Q33627057-8DC7A6F0-CED6-48D6-A4D8-F35207C3DF3BQ34058258-08927407-49DC-4023-96AA-D5A1FEFD60B1Q34272996-3C41F2BD-2EB7-45FB-BEFC-9EB4DEE4FBFFQ34681820-3116FF45-1296-4B46-9881-DED8A6C4F4AEQ35194257-A61B7C05-BAC5-4C64-B410-1A606EDE38CCQ35195563-F508C41D-E935-4F48-AB4C-44D4D3CBEAD2Q35201919-3080A86B-6B82-4F78-97A6-E20AB397A7D1Q35830260-8628B681-7A92-48E1-9F22-9ED8B1C7C286Q35844445-FD2A5223-1E8E-48D8-96E9-F6BB5288A5CCQ35863255-601AADD2-24CE-4A88-8354-A1537FD81C18Q36075753-6A940EF1-1402-4228-B4B0-C425E1CAF54FQ36132380-48E62EEF-EDD8-4341-ACC6-ED5604FD94E6Q36163163-A08C37FE-A2A0-48B2-BCCE-E19C5B18846CQ37045869-170EA88A-FE2A-4357-B3D9-1D399F36174BQ37354195-FEB19BDD-53E9-49DB-B80C-16087E913A4EQ37399730-B95DC664-0992-46E7-A443-E7AEC507309CQ38016072-EBCFC34D-1F43-4AF6-AE68-0538D4E3A78CQ38076334-45DFC2F6-9E18-44C2-AEEA-7AC3D6F91704Q39227459-4E187C3E-6294-4778-816C-440C85C9A0B7Q40157164-A43FE83C-B802-4AC4-A3C0-B0ED36739EFEQ40217274-788ECDD4-51EC-4170-AB39-CA453269F40DQ40328270-2FC73D9D-E251-4A49-8609-691D4BDC8C82Q40473779-72879E7E-8761-4552-99E5-AEA4ECE2AACFQ40858449-EC29A3C6-E64E-43C4-8471-9F5A6E8B3ADAQ41116603-3DFC6214-973E-4207-BBC6-BF826CD32A73Q41134891-A9C40476-8887-467A-BD11-26D5BC67ECE5Q41245366-4E0B5367-E0E3-49F0-960B-B1864CBDFAC7Q41298938-24618D87-D80C-41C9-A7C8-ED34218996F1
P2860
description
1964 nî lūn-bûn
@nan
1964 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1964 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1964年の論文
@ja
1964年論文
@yue
1964年論文
@zh-hant
1964年論文
@zh-hk
1964年論文
@zh-mo
1964年論文
@zh-tw
1964年论文
@wuu
name
HEMOLYTIC COMPLEMENT IN SYNOVIAL FLUID.
@ast
HEMOLYTIC COMPLEMENT IN SYNOVIAL FLUID.
@en
type
label
HEMOLYTIC COMPLEMENT IN SYNOVIAL FLUID.
@ast
HEMOLYTIC COMPLEMENT IN SYNOVIAL FLUID.
@en
prefLabel
HEMOLYTIC COMPLEMENT IN SYNOVIAL FLUID.
@ast
HEMOLYTIC COMPLEMENT IN SYNOVIAL FLUID.
@en
P2860
P356
P1476
HEMOLYTIC COMPLEMENT IN SYNOVIAL FLUID.
@en
P2093
PEKIN TJ Jr
ZVAIFLER NJ
P2860
P304
P356
10.1172/JCI105013
P407
P577
1964-07-01T00:00:00Z